BiDil and racialized medicine

Remember that fascinating piece we read by Jonathan Kahn last semester about the story of BiDil, the first drug with a race-specific indication on its label?  Kahn has a new book out about Bidil and it looks great- amazing sleuthing to uncover the commercial interests and legal manipulation that “produce” race as a viable marketing niche even when our current genomic understanding makes the category absurd.

Advertisements

Add to the discussion

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s